These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38386560)

  • 1. Single-cell spatial transcriptomic and translatomic profiling of dopaminergic neurons in health, aging, and disease.
    Kilfeather P; Khoo JH; Wagner K; Liang H; Caiazza MC; An Y; Zhang X; Chen X; Connor-Robson N; Shang Z; Wade-Martins R
    Cell Rep; 2024 Mar; 43(3):113784. PubMed ID: 38386560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson's Disease.
    Eyer GC; Di Santo S; Hewer E; Andereggen L; Seiler S; Widmer HR
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into Neurodegeneration in Parkinson's Disease from Single-Cell and Spatial Genomics.
    Kamath T; Macosko EZ
    Mov Disord; 2023 Apr; 38(4):518-525. PubMed ID: 36881930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson's disease.
    Benkert J; Hess S; Roy S; Beccano-Kelly D; Wiederspohn N; Duda J; Simons C; Patil K; Gaifullina A; Mannal N; Dragicevic E; Spaich D; Müller S; Nemeth J; Hollmann H; Deuter N; Mousba Y; Kubisch C; Poetschke C; Striessnig J; Pongs O; Schneider T; Wade-Martins R; Patel S; Parlato R; Frank T; Kloppenburg P; Liss B
    Nat Commun; 2019 Nov; 10(1):5094. PubMed ID: 31704946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional deletion of Ndufs4 in dopaminergic neurons promotes Parkinson's disease-like non-motor symptoms without loss of dopamine neurons.
    Choi WS; Kim HW; Tronche F; Palmiter RD; Storm DR; Xia Z
    Sci Rep; 2017 Mar; 7():44989. PubMed ID: 28327638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced dopaminergic neuron degeneration and global transcriptional changes in Parkinson's disease mouse brains engrafted with human neural stems during the early disease stage.
    Pereira MCL; Boese AC; Murad R; Yin J; Hamblin MH; Lee JP
    Exp Neurol; 2022 Jun; 352():114042. PubMed ID: 35271839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson's disease by elevating NPTX2
    Lang Y; Li Y; Yu H; Lin L; Chen X; Wang S; Zhang H
    Aging (Albany NY); 2020 May; 12(9):7660-7678. PubMed ID: 32396526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiomic Analyses of Dopaminergic Neurons Isolated from Human Substantia Nigra in Parkinson's Disease: A Descriptive and Exploratory Study.
    Zaccaria A; Antinori P; Licker V; Kövari E; Lobrinus JA; Burkhard PR
    Cell Mol Neurobiol; 2022 Nov; 42(8):2805-2818. PubMed ID: 34528139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.
    Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA
    J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease.
    Rauschenberger L; Behnke J; Grotemeyer A; Knorr S; Volkmann J; Ip CW
    Neurobiol Dis; 2022 Sep; 171():105798. PubMed ID: 35750147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.
    Dragicevic E; Poetschke C; Duda J; Schlaudraff F; Lammel S; Schiemann J; Fauler M; Hetzel A; Watanabe M; Lujan R; Malenka RC; Striessnig J; Liss B
    Brain; 2014 Aug; 137(Pt 8):2287-302. PubMed ID: 24934288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Cell Transcriptomics of Parkinson's Disease Human In Vitro Models Reveals Dopamine Neuron-Specific Stress Responses.
    Fernandes HJR; Patikas N; Foskolou S; Field SF; Park JE; Byrne ML; Bassett AR; Metzakopian E
    Cell Rep; 2020 Oct; 33(2):108263. PubMed ID: 33053338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression.
    Liu G; Sgobio C; Gu X; Sun L; Lin X; Yu J; Parisiadou L; Xie C; Sastry N; Ding J; Lohr KM; Miller GW; Mateo Y; Lovinger DM; Cai H
    Hum Mol Genet; 2015 Sep; 24(18):5299-312. PubMed ID: 26123485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
    Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
    J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.
    Kordower JH; Olanow CW; Dodiya HB; Chu Y; Beach TG; Adler CH; Halliday GM; Bartus RT
    Brain; 2013 Aug; 136(Pt 8):2419-31. PubMed ID: 23884810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology.
    Simunovic F; Yi M; Wang Y; Macey L; Brown LT; Krichevsky AM; Andersen SL; Stephens RM; Benes FM; Sonntag KC
    Brain; 2009 Jul; 132(Pt 7):1795-809. PubMed ID: 19052140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-specific overexpression of COMT in dopaminergic neurons of Parkinson's disease.
    Kuzumaki N; Suda Y; Iwasawa C; Narita M; Sone T; Watanabe M; Maekawa A; Matsumoto T; Akamatsu W; Igarashi K; Tamura H; Takeshima H; Tawfik VL; Ushijima T; Hattori N; Okano H; Narita M
    Brain; 2019 Jun; 142(6):1675-1689. PubMed ID: 31135049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Rescue of Dopaminergic Neuron Loss in Parkinson's Disease Mice After Transplantation of Hematopoietic Stem and Progenitor Cells.
    Altarche-Xifro W; di Vicino U; Muñoz-Martin MI; Bortolozzi A; Bové J; Vila M; Cosma MP
    EBioMedicine; 2016 Jun; 8():83-95. PubMed ID: 27428421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal cell cycle reentry events in the aging brain are more prevalent in neurodegeneration and lead to cellular senescence.
    Wu D; Sun JK; Chow KH
    PLoS Biol; 2024 Apr; 22(4):e3002559. PubMed ID: 38652714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.